Madrigal Pharmaceuticals, Inc. (MDGL) Balance Sheet

The balance sheet has shifted from a near-debt-free, equity-funded structure toward one with materially larger liabilities, which suggests the company is now carrying obligations that were absent two years ago. The rebound in equity in the latest quarter, combined with rising cash to $514.6M, may indicate renewed external funding or retained operating gains, though the reported figures alone do not disambiguate the two. Investors should monitor whether liability growth continues to outpace equity formation.

The step-up in debt appears to have occurred in 2025Q2, when debt jumped from about $124M to $346M-$354M and has been sustained since, which may reflect a financing decision tied to the commercial launch rather than operating losses alone. A D/E near 0.56 remains manageable relative to the company's cash balance, but the absence of a sustained cash-generating track record means refinancing and servicing capacity depend heavily on continued revenue growth. Investors should monitor debt maturity terms, which are not included in the supplied data.

A current ratio above 3 indicates ample short-term asset coverage, but the sharp decline from earlier levels reflects rising current liabilities that grew faster than the asset base. Cash reserves have fluctuated widely rather than building steadily, which suggests the buffer against operating shocks is dependent on the timing of collections and financing inflows. The combination of volatile cash and rising liabilities warrants further investigation into the composition of current obligations.

The accumulated deficit of this magnitude implies that the equity base is almost entirely composed of contributed capital, consistent with a company that has historically relied on equity markets to fund development. The modest goodwill of $7.1M and minimal PPE of $26.8M indicate little tangible asset backing beyond cash. Stock-based compensation is not separately reported in the balance sheet data, so dilution effects cannot be quantified from the supplied figures.